<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Antibiotic treatment, duration of infectiousness, and disease transmission - Health AI Hub</title>
    <meta name="description" content="This paper presents a counter-intuitive hypothesis: while antibiotic therapy cures individuals, it might, under specific conditions, increase the overall durati">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Antibiotic treatment, duration of infectiousness, and disease transmission</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2011.01548v1" target="_blank">2011.01548v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2020-11-02
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Thomas Caraco
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.PE
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.90 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2011.01548v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2011.01548v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper presents a counter-intuitive hypothesis: while antibiotic therapy cures individuals, it might, under specific conditions, increase the overall duration of infectiousness and consequently boost between-host disease transmission. This occurs because antibiotics' suppression of within-host pathogen density can reduce the probability of a host being removed from infectious status by non-treatment means (e.g., isolation due to severe symptoms or mortality), especially when these removal events are pathogen-density dependent.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research highlights a crucial, often overlooked, epidemiological consequence of antibiotic use beyond individual patient cure. It suggests that treatment strategies must consider not only within-host pathogen clearance but also the potential broader public health impact on disease transmission dynamics, especially in an era of increasing antimicrobial resistance and sub-optimal drug regimens.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>Not applicable. The abstract describes a deterministic modeling approach to understand biological dynamics, not an application of AI or machine learning.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Antibiotic treatment, conventionally thought to limit disease spread, is proposed to potentially increase it under certain conditions.</li>
                    
                    <li>The core mechanism is that antibiotic-induced suppression of within-host pathogen density can relax other host removal rates (e.g., isolation, mortality) that depend on high pathogen density.</li>
                    
                    <li>This relaxation of overall removal rates can prolong the duration of a host's infectiousness.</li>
                    
                    <li>The research employs a deterministic within-host dynamics model to simulate time-dependent transmission probability and probabilistic duration of the infectious period.</li>
                    
                    <li>The model varies key parameters including inoculum size, bacterial self-regulation, time from infection to therapy initiation, antibiotic efficacy (within-host), and between-host encounter dynamics.</li>
                    
                    <li>Results identify specific conditions, particularly at lower antibiotic efficacy, where treatment increases infectiousness duration and the expected number of new infections.</li>
                    
                    <li>A significant implication is that lower antibiotic efficacy might convert a rare, serious bacterial disease into a common, but treatable infection, altering disease epidemiology.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study utilizes a deterministic mathematical model focusing on within-host bacterial dynamics. This within-host model drives the time-dependent probability of disease transmission and the probabilistic duration of the infectious period. It integrates factors like inoculum size, bacterial self-regulation, timing of antibiotic initiation, and antibiotic efficacy at the within-host scale, alongside between-host factors such as the size and susceptibility of encountered groups.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The primary finding is the identification of conditions under which antibiotic treatment can paradoxically increase the duration of a host's infectiousness, thereby increasing the expected number of new infections. This effect is particularly pronounced when antibiotic efficacy is lower, suggesting that such treatments might transform rare, severe bacterial diseases into more common, albeit treatable, infections.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research mandates a re-evaluation of antibiotic treatment guidelines and antimicrobial stewardship programs. Clinicians and public health authorities may need to consider not just clearing infection but also optimizing treatment duration and efficacy to prevent inadvertently prolonging infectiousness. It suggests that treatments leading to partial pathogen suppression, rather than complete eradication, could have detrimental community-level transmission consequences, influencing decisions on antibiotic choice, dosing, and duration.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state specific limitations of the study. However, as a modeling study, inherent limitations typically include reliance on simplified assumptions regarding host-pathogen interactions, the deterministic nature potentially overlooking stochastic events, and the necessity for empirical validation of the model's parameters and predictions in real-world clinical and epidemiological settings.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Future research directions are not explicitly mentioned in the abstract. However, logical extensions would include empirical validation of the model's predictions, incorporating host immune responses, exploring the impact of antibiotic resistance evolution within the model, and applying the framework to specific bacterial diseases with well-characterized within-host and between-host dynamics.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Infectious Disease Epidemiology</span>
                    
                    <span class="tag">Public Health</span>
                    
                    <span class="tag">Clinical Microbiology</span>
                    
                    <span class="tag">Antimicrobial Stewardship</span>
                    
                    <span class="tag">Pharmacology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Antibiotic treatment</span>
                    
                    <span class="tag tag-keyword">Disease transmission</span>
                    
                    <span class="tag tag-keyword">Infectiousness duration</span>
                    
                    <span class="tag tag-keyword">Within-host dynamics</span>
                    
                    <span class="tag tag-keyword">Pathogen density</span>
                    
                    <span class="tag tag-keyword">Epidemiological modeling</span>
                    
                    <span class="tag tag-keyword">Antibiotic efficacy</span>
                    
                    <span class="tag tag-keyword">Public health</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Humans, domestic animals, orchard crops, and ornamental plants are commonly treated with antibiotics in response to bacterial infection. By curing infectious individuals, antibiotic therapy might limit the spread of contagious disease among hosts. But an antibiotic`s suppression of within-host pathogen density might also reduce the probability that the host is otherwise removed from infectious status prior to therapeutic recovery. When rates of both recovery via treatment and other removal events (e.g., isolation or mortality) depend directly on within-host pathogen density, antibiotic treatment can relax the overall removal rate sufficiently to increase between-host disease transmission. To explore this dependence, a deterministic within-host dynamics drives the infectious host's time-dependent probability of disease transmission, as well as the probabilistic duration of the infectious period. At the within-host scale, the model varies (1) inoculum size, (2) bacterial self-regulation, (3) the time between infection and initiation of therapy, and (4) antibiotic efficacy. At the between-host scale the model varies (5) the size/susceptibility of groups randomly encountered by an infectious host. Results identify conditions where antibiotic treatment can increase duration of a host`s infectiousness, and consequently increase the expected number of new infections. At lower antibiotic efficacy, treatment might convert a rare, serious bacterial disease into a common, but treatable infection.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>25 pages of text, 5 figures, 1 table. arXiv admin note: substantial text overlap with arXiv:2001.06948</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>